The latest information on Seripas (BRINEURA) price and market reference price per box

Sereparasase (BRINEURA) is a recombinant enzyme preparation used to treat neuronal storage disease 2 type (CLN2), a rare neurodegenerative disease in children. By replacing missing or abnormal enzymes, the drug slows down the neurodegenerative process and delays the decline of patients' motor and speech abilities. It is currently one of the targeted treatments for this disease. Due to its special treatment targets, the drug market demand is mainly concentrated in sick children.

As of now, BRINEURA has not been launched in China, so domestic patients cannot purchase it directly in hospitals or pharmacies. If patients need medication, they must obtain it through formal overseas procurement channels, such as certified international drug suppliers or cross-border medical platforms. Prescriptions and relevant diagnostic information must be provided when purchasing, and cross-border transportation and customs management regulations must be strictly followed to ensure that the drugs are legal and safe.

The overseas market price of BRINEURA is higher, per bottle150mg/5 The ml size is priced at approximately USD 16,190.17 while the standard packaging is a box of two bottles, with a total price of USD 32,380.33. The high price is mainly related to the drug's research and development costs, rarity of indications, and complexity of the production process. For domestic families, long-term treatment costs are very high, so economic conditions and treatment necessity need to be fully evaluated.

Since it is not yet available and covered by medical insurance in China, patients can pay attention to the patient assistance programs (PAP) of pharmaceutical companies or international charity projects, which can provide partial subsidies or drug discounts to some families. During the period of using BRINEURA, it is also necessary to take medication under the guidance of a professional doctor, regularly monitor the efficacy and adverse reactions, and cooperate with rehabilitation treatment to maximize the efficacy. Reasonable planning of procurement and medication plans can help patients obtain the best treatment results within an affordable range.

Reference materials:https://www.drugs.com/